Lytix Biopharma AS
OSE:LYTIX
Lytix Biopharma AS?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.76
12.25
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Lytix Biopharma AS hold over its rivals?
What risks and challenges
does Lytix Biopharma AS face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Lytix Biopharma AS.
Provide an overview of the primary business activities
of Lytix Biopharma AS.
What unique competitive advantages
does Lytix Biopharma AS hold over its rivals?
What risks and challenges
does Lytix Biopharma AS face in the near future?
Summarize the latest earnings call
of Lytix Biopharma AS.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Lytix Biopharma AS.
Provide P/S
for Lytix Biopharma AS.
Provide P/E
for Lytix Biopharma AS.
Provide P/OCF
for Lytix Biopharma AS.
Provide P/FCFE
for Lytix Biopharma AS.
Provide P/B
for Lytix Biopharma AS.
Provide EV/S
for Lytix Biopharma AS.
Provide EV/GP
for Lytix Biopharma AS.
Provide EV/EBITDA
for Lytix Biopharma AS.
Provide EV/EBIT
for Lytix Biopharma AS.
Provide EV/OCF
for Lytix Biopharma AS.
Provide EV/FCFF
for Lytix Biopharma AS.
Provide EV/IC
for Lytix Biopharma AS.
Show me price targets
for Lytix Biopharma AS made by professional analysts.
What are the Revenue projections
for Lytix Biopharma AS?
How accurate were the past Revenue estimates
for Lytix Biopharma AS?
What are the Net Income projections
for Lytix Biopharma AS?
How accurate were the past Net Income estimates
for Lytix Biopharma AS?
What are the EPS projections
for Lytix Biopharma AS?
How accurate were the past EPS estimates
for Lytix Biopharma AS?
What are the EBIT projections
for Lytix Biopharma AS?
How accurate were the past EBIT estimates
for Lytix Biopharma AS?
Compare the revenue forecasts
for Lytix Biopharma AS with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Lytix Biopharma AS and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Lytix Biopharma AS against its competitors.
Analyze the profit margins
(gross, operating, and net) of Lytix Biopharma AS compared to its peers.
Compare the P/E ratios
of Lytix Biopharma AS against its peers.
Discuss the investment returns and shareholder value creation
comparing Lytix Biopharma AS with its peers.
Analyze the financial leverage
of Lytix Biopharma AS compared to its main competitors.
Show all profitability ratios
for Lytix Biopharma AS.
Provide ROE
for Lytix Biopharma AS.
Provide ROA
for Lytix Biopharma AS.
Provide ROIC
for Lytix Biopharma AS.
Provide ROCE
for Lytix Biopharma AS.
Provide Gross Margin
for Lytix Biopharma AS.
Provide Operating Margin
for Lytix Biopharma AS.
Provide Net Margin
for Lytix Biopharma AS.
Provide FCF Margin
for Lytix Biopharma AS.
Show all solvency ratios
for Lytix Biopharma AS.
Provide D/E Ratio
for Lytix Biopharma AS.
Provide D/A Ratio
for Lytix Biopharma AS.
Provide Interest Coverage Ratio
for Lytix Biopharma AS.
Provide Altman Z-Score Ratio
for Lytix Biopharma AS.
Provide Quick Ratio
for Lytix Biopharma AS.
Provide Current Ratio
for Lytix Biopharma AS.
Provide Cash Ratio
for Lytix Biopharma AS.
What is the historical Revenue growth
over the last 5 years for Lytix Biopharma AS?
What is the historical Net Income growth
over the last 5 years for Lytix Biopharma AS?
What is the current Free Cash Flow
of Lytix Biopharma AS?
Discuss the annual earnings per share (EPS)
trend over the past five years for Lytix Biopharma AS.
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
NO |
L
|
Lytix Biopharma AS
OSE:LYTIX
|
332.4m NOK | -4.1 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | -167 520.3 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
309B USD | 72.9 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
153.7B USD | 37.6 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
129.1B USD | 269 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.4B USD | -232.3 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -510 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
111.4B AUD | 25.5 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
60.7B USD | 13.8 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -59 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
29.2B EUR | 39.4 |
|
Earnings Growth | PEG | |||||
---|---|---|---|---|---|---|
NO |
L
|
Lytix Biopharma AS
OSE:LYTIX
|
Average P/E:
76.4
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -167 520.3 | N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
72.9
|
87%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
37.6
|
44%
|
0.9 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
269
|
187%
|
1.4 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Negative Multiple: -232.3 | N/A | N/A |
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -510 | N/A | N/A |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
25.5
|
16%
|
1.6 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
13.8
|
12%
|
1.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -59 | N/A | N/A |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
39.4
|
26%
|
1.5 |
|
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.